Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $85.68 in the prior trading day, Dexcom Inc (NASDAQ: DXCM) closed at $84.82, down -1.00%. In other words, the price has decreased by -$1.00 from its previous closing price. On the day, 1.42 million shares were traded.
Ratios:
Our goal is to gain a better understanding of DXCM by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 57.82. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 1.14 whereas as Long-Term Debt/Eq ratio is at 0.60.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on May 30, 2025, initiated with a Buy rating and assigned the stock a target price of $104.
Redburn Atlantic Upgraded its Neutral to Buy on February 03, 2025, whereas the target price for the stock was revised from $85 to $115.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 09 ’25 when AUGUSTINOS NICHOLAS bought 6,290 shares for $86.91 per share.
Stern Sadie sold 6,184 shares of DXCM for $526,318 on May 27 ’25. The EVP, Chief HR Officer now owns 109,621 shares after completing the transaction at $85.11 per share. On May 23 ’25, another insider, Brown Michael Jon, who serves as the EVP, Chief Legal Officer of the company, sold 10,000 shares for $84.28 each. As a result, the insider received 842,849 and left with 95,602 shares of the company.
Valuation Measures:
As of this moment, Dexcom’s Price-to-Earnings (P/E) ratio for their current fiscal year is 63.67, and their Forward P/E ratio for the next fiscal year is 33.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.67. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.02 while its Price-to-Book (P/B) ratio in mrq is 14.67.
Stock Price History:
Over the past 52 weeks, DXCM has reached a high of $118.80, while it has fallen to a 52-week low of $57.52. The 50-Day Moving Average of the stock is 10.34%, while the 200-Day Moving Average is calculated to be 10.92%.
Shares Statistics:
A total of 392.10M shares are outstanding, with a floating share count of 386.47M. Insiders hold about 1.44% of the company’s shares, while institutions hold 93.64% stake in the company.
